Myriad Reports 31 Percent Jump in Q4 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that its fourth quarter revenues climbed 31 percent year over year partially driven by a 19 percent increase in revenue for its flagship BRACAnalysis test.

The Salt Lake City-based molecular diagnostics firm brought in total revenues of $174.1 million for the three months ended June 30, compared to revenues of $133 million for the fourth quarter of 2012. It beat the consensus Wall Street estimate for revenues of $159.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.